Precision Neuroscience

New York, NY · Founded 2021 · Privately Held (backing)

Developer of a brain-computer interface device technology designed to provide effective treatment for patients with neurological illnesses. Precision Neuroscience is based in New York, NY and was founded in 2021. It was valued at $529 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $179 million across 4 recorded rounds; the latest was a $93.1 million later-stage round in Oct 2024.

PMV mark · valuation
$529.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$179.1M
Last round
Later Stage VC
Oct 2024
What is Precision Neuroscience worth?
$529.0MPrivateMarketView mark · Oct 2026

Valued at $529.0M at its later-stage round, Oct 2024. Nothing has traded since.

Free account
More of Precision Neuroscience with a free account
  • ·The complete investor list: 17 names
  • ·Watch Precision Neuroscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Precision Neuroscience funding history

4 rounds
DateRoundRaisedPost-money
Oct 2024Later Stage VC$93.1M▮
Mar 2024Early Stage VC$27.5M▮
Dec 2022Early Stage VC$41.2M▮
Apr 2021Early Stage VC$10.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Precision Neuroscience valuation

Precision Neuroscience was valued at $529 million at its later-stage round in Oct 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Precision Neuroscience raised?

Precision Neuroscience has raised $179 million across 4 recorded rounds since 2021. The largest was a $93.1 million later-stage round in Oct 2024.

Precision Neuroscience has filed 5 Form Ds with the SEC since 2021, most recently in Oct 2024 ($93.1 million sold to 21 investors).

How Precision Neuroscience's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Precision Neuroscience, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Precision Neuroscience

What is Precision Neuroscience worth?
Precision Neuroscience is valued at $529.0M as of Oct 2026. Valued at $529.0M at its later-stage round, Oct 2024. Nothing has traded since.
How much has Precision Neuroscience raised?
Precision Neuroscience has raised $179.1M in total funding across 4 recorded rounds.
When did Precision Neuroscience last raise?
Precision Neuroscience last raised in Oct 2024 (Later Stage VC), raising $93.1M.